10:14 AM EST - Medicenna Therapeutics Corp. : Today reported financial results and corporate highlights for the fiscal quarter ended September 30, 2024. The Company reported a net loss of $4.2 million ($0.05 per share) compared to a net loss of $3.7 million ($0.05 per share) for the three months ended September 30, 2023. Medicenna Therapeutics Corp.
shares T.MDNA are trading down $0.07 at $1.63.
